Inactive Instrument
Quotes Celsion Corporation Nasdaq
Stocks
US15117N3052
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 09-24 | IMUNON, Inc. Presents Update On IMNN-001 Development Program For Women With Newly Diagnosed Advanced Ovarian Cancer | CI |
| 09-23 | Imunon, Inc. - Shareholder/Analyst Call |
Stock exchange
Basic data
Market Cap (USD)
5,527,231
Net sales (USD)
0
Free-Float
93.73%
Free-Float capitalization (USD)
5,180,462
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 5.53M | |
| +0.79% | -6.16% | +49.32% | +74.50% | 65.83B | |
| +1.92% | +10.35% | +13.02% | +87.74% | 51.87B | |
| +6.91% | +8.57% | +6.88% | +72.12% | 51.2B | |
| +0.74% | +2.75% | +26.31% | +45.29% | 43.76B | |
| +3.87% | +10.15% | +20.69% | +132.73% | 42.09B | |
| +7.91% | +4.30% | +263.91% | +602.72% | 39.04B | |
| -0.40% | +9.85% | +17.04% | +59.17% | 34B | |
| -0.50% | +0.44% | +38.70% | +8.26% | 25.2B | |
| +2.36% | +5.34% | +30.98% | +26.07% | 22.8B | |
| Average | +2.66% | +1.67% | +51.87% | +123.18% | 37.58B | |
| Weighted average by Cap. | +2.78% | +2.01% | +50.19% | +125.23% |
Historical Quotes: Celsion Corporation
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- IMNN Stock
- Stock
- Quotes Celsion Corporation
Select your edition
All financial news and data tailored to specific country editions
